Fabrication of biofunctional stents with endothelial progenitor cell specificity for vascular re-endothelialization

Colloids and Surfaces B: Biointerfaces

Volumn 102, Issue , 2013, Pages 744-751

  Kang, Chan Koo ^a,b,c   Lim, Woo Hyun ^d   Kyeong, San ^a   Choe, Won Seok ^d   Kim, Hyo Soo ^d   Jun, Bong Hyun ^b   Lee, Yoon Sik ^a,b  

^a School of Chemical and Biological Engineering   (South Korea)

^b Seoul National University   (South Korea)

^c Samsung Advanced Institute of Technology (SAIT)   (South Korea)

^d Seoul National University Hospital   (South Korea)

Author keywords

Anti VE cadherin antibody; Endothelial progenitor cell; Polymer grafting; Stent; Surface modification

Indexed keywords

ANTIBODY IMMOBILIZATION; ANTIBODY-ANTIGEN INTERACTIONS; BIOCOMPATIBLE SURFACES; COVALENT ATTACHMENT; ENDOTHELIAL PROGENITOR CELLS; HYDROPHILIC POLYMERS; IN-VITRO; LEUKEMIA CELLS; MEDICAL DEVICES; MODIFICATION TECHNOLOGY; NEOINTIMAL HYPERPLASIA; POLYMER GRAFTING; SILANIZATIONS; STENT; STENTING; SURFACE MARKERS; SURFACE-MODIFIED; VE-CADHERIN;

BIOCOMPATIBILITY; BIOMEDICAL EQUIPMENT; DISEASES; ENDOTHELIAL CELLS; FUNCTIONAL GROUPS; GLYCOPROTEINS; GRAFTING (CHEMICAL); HEART VALVE PROSTHESES; POLYMERS; STENTS; SURFACE TREATMENT;

ANTIBODIES;

ACID; MONOCLONAL ANTIBODY; POLYMER; SILANE; STAINLESS STEEL; VASCULAR ENDOTHELIAL CADHERIN;

ADSORPTION; ARTICLE; BIOCOMPATIBILITY; CELL SPECIFICITY; CHEMICAL MODIFICATION; CONJUGATION; COVALENT BOND; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HISTOGENESIS; HUMAN; HUMAN CELL; HYDROPHILICITY; IN VITRO STUDY; LEUKEMIA CELL; MEDICAL DEVICE; PRIORITY JOURNAL; REENDOTHELIALIZATION; STENT; SURFACE PROPERTY;

CADHERINS; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, CONFOCAL; POLYMERS; STEM CELLS; STENTS;

EID: 84867803723     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.09.008     Document Type: Article

References (38)

1. O'Brien B., Carroll W. The evolution of cardiovascular stent materials and surfaces in response to clinical drivers: a review. Acta Biomater. 2009, 5:945.
2. Tirrell M., Kokkoli E., Biesalski M. The role of surface science in bioengineered materials. Surf. Sci. 2002, 500:61.
3. Yoon C.H., Hur J., Park K.W., Kim J.H., Lee C.S., Oh I.Y., Kim T.Y., Cho H.J., Kang H.J., Chae I.H., Yang H.K., Oh B.H., Park Y.B., Kim H.S. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells - the role of angiogenic cytokines and matrix metalloproteinases. Circulation 2005, 112:1618.
4. Abrahams J.M., Diamond S.L., Hurst R.W., Zager E.L., Grady M.S. Topic review: surface modifications enhancing biological activity of Guglielmi detachable coils in treating intracranial aneurysms. Surg. Neurol. 2000, 54:34.
5. Kukreja N., Onuma Y., Daemen J., Serruys P.W. The future of drug-eluting stents. Pharmacol. Res. 2008, 57:171.
6. Bertrand O.F., Sipehia R., Mongrain R., Rodes J.R., Tardif J.C., Bilodeau L., Cote G., Bourassa M.G. Biocompatibility aspects of new stent technology. J. Am. Coll. Cardiol. 1998, 32:562.
7. Lahann J., Klee D., Thelen H., Bienert H., Vorwerk D., Hocker H. Improvement of haemocompatibility of metallic stents by polymer coating. J. Mater. Sci.: Mater. Med. 1999, 10:443.
8. Lewis A.L., Cumming Z.L., Goreish H.H., Kirkwood L.C., Tolhurst L.A., Stratford P.W. Crosslinkable coatings from phosphorylcholine-based polymers. Biomaterials 2001, 22:99.
9. Palmaz J.C., Bailey S., Marton D., Sprague E. Influence of stent design and material composition on procedure outcome. J. Vasc. Surg. 2002, 36:1031.
10. Seeger J.M., Ingegno M.D., Bigatan E., Klingman N., Amery D., Widenhouse C., Goldberg E.P. Hydrophilic surface modification of metallic endoluminal stents. J. Vasc. Surg. 1995, 22:327.
11. Blindt R., Vogt F., Astafieva I., Fach C., Hristov M., Krott N., Seitz B., Kapurniotu A., Kwok C., Dewor M., Bosserhoff A.-K., Bernhagen J., Hanrath P., Hoffmann R., Weber C. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. J. Am. Coll. Cardiol. 2006, 47:1786.
12. Fattori R., Piva T. Drug-eluting stents in vascular intervention. Lancet 2003, 361:247.
13. Hara H., Nakamura M., Palmaz J.C., Schwartz R.S. Role of stent design and coatings on restenosis and thrombosis. Adv. Drug. Deliv. Rev. 2006, 58:377.
14. Kim T.G., Lee H., Jang Y., Park T.G. Controlled release of paclitaxel from heparinized metal stent fabricated by layer-by-layer assembly of polylysine and hyaluronic acid-g-poly(lactic-co-glycolic acid) micelles encapsulating paclitaxel. Biomacromolecules 2009, 10:1532.
15. Takahashi H., Letourneur D., Grainger D.W. Delivery of large biopharmaceuticals from cardiovascular stents: a review. Biomacromolecules 2007, 8:3281.
16. Garg S., Serruys P.W. Coronary stents. J. Am. Coll. Cardiol. 2010, 56:S43.
17. Luscher T.F., Steffel J., Eberli F.R., Joner M., Nakazawa G., Tanner F.C., Virmani R. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 2007, 115:1051.
18. de Mel A., Jell G., Stevens M.M., Seifalian A.M. Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review. Biomacromolecules 2008, 9:2969.
19. Kawamoto A., Asahara T. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies. Catheter. Cardiovasc. Intervent. 2007, 70:477.
20. Meyers S.R., Kenan D.J., Khoo X.J., Grinstaff M.W. Bioactive stent surface coating that promotes endothelialization while preventing platelet adhesion. Biomacromolecules 2011, 12:533.
21. Aoki J., Serruys P.W., van Beusekom H., Ong A.T.L., McFadden E.P., Sianos G., van der Giessen W.J., Regar E., de Feyter P.J., Davis H.R., Rowland S., Kutryk M.J.B. Endothelial progenitor cell capture by stents coated with antibody against CD34. J. Am. Coll. Cardiol. 2005, 45:1574.
22. Chong E., Poh K.K., Liang S., Lee R.C.-H., Low A., Teo S.-G., Tan H.C. Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for st elevation myocardial infarction. J. Intervent. Cardiol. 2010, 23:101.
23. Szmitko P.E., Kutryk M.J.B., Stewart D.J., Strauss M.H., Verma S. Endothelial progenitor cell-coated stents under scrutiny. Can. J. Cardiol. 2006, 22:1117.
24. Wendel H.P., Avci-Adali M., Ziemer G. Endothelial progenitor cell capture stents - hype or hope?. Int. J. Cardiol. 2010, 145:115.
25. Yin M., Yuan Y., Liu C., Wang J. Combinatorial coating of adhesive polypeptide and anti-CD34 antibody for improved endothelial cell adhesion and proliferation. J. Mater. Sci. Mater. Med. 2009, 20:1513.
26. Garg S., Duckers H.J., Serruys P.W. Endothelial progenitor cell capture stents: will this technology find its niche in contemporary practice?. Eur. Heart J. 2010, 31:1032.
27. Cheng F., Shang J., Ratner D.M. A versatile method for functionalizing surfaces with bioactive glycans. Bioconjugate Chem. 2011, 22:50.
28. Falsey J.R., Renil M., Park S., Li S.J., Lam K.S. Peptide and small molecule microarray for high throughput cell adhesion and functional assays. Bioconjugate Chem. 2001, 12:346.
29. Kang C.K., Lee Y.S. The surface modification of stainless steel and the correlation between the surface properties and protein adsorption. J. Mater. Sci.: Mater. Med. 2007, 18:1389.
30. Carmeliet P., Lampugnani M.G., Moons L., Breviario F., Compernolle V., Bono F., Balconi G., Spagnuolo R., Oosthuyse B., Dewerchin M., Zanetti A., Angellilo A., Mattot V., Nuyens D., Lutgens E., Clotman F., de Ruiter M.C., Gittenberger-de Groot A., Poelmann R., Lupu F., Herbert J.M., Collen D., Dejana E. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell 1999, 98:147.
31. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., Oh B.H., Lee M.M., Park Y.B. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscl. Thromb. Vasc. 2004, 24:288.
32. Otsuka H., Nagasaki Y., Kataoka K. PEGylated nanoparticles for biological and pharmaceutical applications. Adv. Drug. Deliv. Rev. 2003, 55:403.
33. Shin D.-S., Lee K.-N., Jang K.-H., Kim J.-K., Chung W.-J., Kim Y.-K., Lee Y.-S. Protein patterning by maskless photolithography on hydrophilic polymer-grafted surface. Biosens. Bioelectron. 2003, 19:485.
34. Tomizaki K.Y., Usui K., Mihara H. Protein-detecting microarrays: current accomplishments and requirements. Chembiochem 2005, 6:783.
35. Zhao H., Van Humbeeck J., Sohier J., De Scheerder I. Electrochemical polishing of 316L stainless steel slotted tube coronary stents. J. Mater. Sci.: Mater. Med. 2002, 13:911.
36. Mansfeld F., Breslin C.B., Pardo A., Perez F.J. Surface modification of stainless steels: Green technology for corrosion protection. Surf. Coat. Technol. 1997, 90:224.
37. Miyazu K., Kawahara D., Ohtake H., Watanabe G., Matsuda T. Luminal surface design of electrospun small-diameter graft aiming at in situ capture of endothelial progenitor cell. J. Biomed. Mater. Res. Part B 2010, 94B:53.
38. Lim W.H., Seo W.W., Choe W., Kang C.K., Park J., Cho H.J., Kyeong S., Hur J., Yang H.M., Cho H.J., Lee Y.S., Kim H.S. Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation. Arterioscl. Thromb. Vasc. 2011, 31:2798.